Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -0.06 | -0.10 | -3.86 | -0.24 |
Depreciation/ Depletion | 0.00 | 0.00 | 0.00 | 0.00 |
Non- Cash Items | -0.03 | -0.03 | -0.06 | -0.14 |
Changesin Working Capital | 0.08 | -0.02 | -0.10 | -0.02 |
Cashfrom Operating Activities | 0.00 | -0.15 | -4.01 | -0.40 |
Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Cash Flow Items Total | 0.08 | -0.12 | 3.81 | 0.53 |
Cashfrom Investing Activities | 0.08 | -0.12 | 3.81 | 0.53 |
Issuance( Retirement)of Debt Net | -0.06 | 0.06 | 0.33 | -0.07 |
Cashfrom Financing Activities | -0.06 | 0.06 | 0.33 | -0.07 |
Net Changein Cash | 0.01 | -0.20 | 0.13 | 0.06 |
Cash Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 |
Bacil Pharma Dividend Bacil Pharma Bonus Bacil Pharma News Bacil Pharma AGM Bacil Pharma Rights Bacil Pharma Splits Bacil Pharma Board Meetings Bacil Pharma Key Metrics Bacil Pharma Shareholdings Bacil Pharma Profit Loss Bacil Pharma Balance Sheet Bacil Pharma Q1 Results Bacil Pharma Q2 Results Bacil Pharma Q3 Results Bacil Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks